dc.description.abstract |
Lung cancer remains one of the leading causes of cancer-related deaths
worldwide, primarily because it is often diagnosed at an advanced stage when
treatment options are less effective. In many cases, early-stage lung cancer
is asymptomatic, meaning that patients do not experience noticeable symp-
toms until the disease has progressed. This delay in symptom onset leads
to a higher likelihood of late detection, by which point tumors may have
spread beyond the lungs, significantly reducing the effectiveness of available
treatments like surgery, radiation, and chemotherapy. Moreover, the subtle
and small size of early-stage lung nodules makes them difficult to detect in
medical imaging, as they can easily be missed or misinterpreted by radiolo-
gists. Therefore, improving early detection methods is critical for increasing
survival rates, as early-stage diagnosis allows for more timely intervention,
potentially curative treatments, and better overall patient outcomes.
This work investigates advanced methodologies for the early detection
and classification of lung cancer, leveraging cutting-edge object detection
and deep learning techniques. Lung nodules, often considered one of the
earliest indicators of lung cancer, are critical to identify accurately to enhance
early diagnosis and improve patient outcomes. To address this, we employ
the YOLOv7 architecture, renowned for its speed and precision, to detect
lung nodules in medical images, with a particular focus on identifying small,
subtle nodules that are often challenging to detect using standard imaging
techniques.
Following the detection phase, we utilize transfer learning with the pre-
trained VGG16 model for the classification of the detected nodules. Transfer
learning allows us to harness the power of VGG16’s deep feature extraction
while fine-tuning the model to be highly sensitive to lung nodule characteris-
tics. Together, these techniques enhance the accuracy, reliability, and speed
of nodule detection and classification, addressing the significant challenge of
early-stage lung cancer identification. By integrating these models, our ap-
proach not only improves diagnostic precision but also serves as a valuable
tool for radiologists, aiding them in making more informed, data-driven de-
cisions in clinical practice. |
en_US |